Innogen · People · Innogen Associates
Dr Jack Scannell

Innogen Institute Honorary Fellow

Jack.Scannell@ed.ac.uk

School of Social and Political Science
Innogen Institute
Old Surgeon’ s Hall
High School Yards
University of Edinburgh
EH1 1LZ

uk.linkedin.com/

Dr Scannell has experience in commercial, financial and scientific aspects of drug R&D. He is an Associate Fellow of the Center for the Advancement of Sustainable Medical Innovation (CASMI) at Oxford University.

He is conducting research of the causes of what has been a long-term decline in R&D productivity in the biotechnology and pharmaceutical industries. This includes analysis of trends in financial returns on R&D investment and analysis of the scientific and technical barriers to drug discovery. Dr Scannell also does commercial consulting work in the drug industry.

Before returning to academia in July 2014, Dr Scannell was Head of Discovery Research at a e-Therapeutics PLC, an Oxford-based biotechnology firm. From 2005 to 2012, Dr Scannell worked in financial markets, and was involved in drug industry investment. He ran the European Healthcare team at Sanford Bernstein in London. Dr Scannell joined Bernstein from the Boston Consulting Group (BCG), and prior to BCG he was an academic biomedical scientist, first at Oxford and then at Newcastle University.

Dr Scannell has a degree in Medical Sciences from Cambridge University and a PhD in Physiology (Computational Neuroscience) from Oxford University.

Completed research

Publications